TrialJournal of inherited metabolic disease2025

Long-Term Safety and Clinical Outcomes With Olipudase Alfa Enzyme Replacement Therapy in Children and Adolescents With Acid Sphingomyelinase Deficiency.

Maurizio Scarpa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.